Menopause-related changes in lipoproteins and some other cardiovascular risk factors

International Journal of Epidemiology

Volumn 19, Issue 1, 1990, Pages 42-48

  Bonithon kopp, Claire ^a   Scarabin, Pierre Yves ^a   Darne, Bernadette ^b   Malmejac, Alain ^b   Guize, Louis ^b  

^a HÔPITAL BROUSSAIS   (France)

^b Centre des Investigations Précliniques de Paris ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; NORMAL HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

CORONARY DISEASE; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC FACTORS; FEMALE; HUMAN; LIPOPROTEINS, LDL; MENOPAUSE; MIDDLE AGE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0025231692     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/19.1.42     Document Type: Article

References (37)

1. Parrish H M, Carr L A. Hall D G, King T M. Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstei Gynecol 1967; 99: 155-62.
2. Bengtsson C, Rybo G, Westerberg H. Number of pregnancies, use of oral contraceptives and menopausal age in women with ischaemic heart disease, compared to a population sample of women. Ada Med Scand 1973 (suppl); 549: 75-81.
3. Gordon T. Kannel W B. Hjortland M C. McNamara P M. Menopause and coronary heart disease. Ann Intern Med 1978; 89: 157-61.
4. Rosenberg L, Hcnnekens C H, Rosner B. Belanger C, Rothman K J, Speizer F E. Early menopause and the risk of myocardial infarction. Am J Obslet Gynecol 1981; 139: 47-51.
5. Svanberg L. Effects of estrogen deficiency in women castrated when young. Acta Obstei Gynecol Scand 1982 (suppl); 106: 11-15.
6. Colditz G A. Willett W C, Stampfer M J, Rosner B, Speizer F E, Hennekens C H. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105-10.
7. Weiss N S. Relationship of menopause to serum cholesterol and arterial blood pressure: The United States health examination survey of dults. Am J Epidemiol 1972; 96: 237-41.
8. Kannel W B, Hjortland M C, McNamara P M, Gordon T., Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med 1976; 85: 447-52.
9. Hjortland M C, McNamara P M, Kannel W B., Some atherogenic concomitants of menopause; The Framingham Study. Am J Epidemiol 1976; 103: 304-11.
10. Bengtsson C, Lindquist O. Menopausal effects on risk factors for ischaemic heart disease. Maluritas 1979; 1: 165-70.
11. Shibata H, Matsuzaki T, Hatano S., Relationship of relevant factors of atherosclerosis to menopause in Japanese women. Am J Epidemiol 1979; 109: 420-4.
12. Lindquist O., Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: Results from a prospective population study of women in Goteborg, Sweden. Prev Med 1982; II: 162-72.
13. Baird D D, Tyroler H A, Heiss G, Chambless L E, Hames C G. Menopausal change in serum cholesterol: Black/white differences in Evans County, Georgia. Am J Epidemiol 1985; 122: 982-93.
14. Shibata H, Haga H, Suyama Y, Kumagai S, Seino T. Serum total and HDL cholesterols according to reproductive status in Japanese females. J Chron Dis 1987; 40: 209-13.
15. Avogaro P, Bittolo Bon G, Cazzolato G, Ouinci G B. Are apolipoproteins better discriminators than lipids for atherosclerosis. Lancet 1979; 1: 901-3.
16. Durrington P N, Hunt L, Ishola M, Kane J, Stephens W P. Serum apolipoproteins Al and B and lipoproteins in middle-aged men with and without previous myocardial infarction. Br Heart J 1986; 56: 206-12.
17. Hamsten A, Walldius G, Szamosi A, Dahlen G, De Faire U. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation 1986; 73: 1097-110.
18. Kottke B A, Zinsmeister A R, Holmes D R, et al., Apolipoproteins and coronary artery disease. Mayo Clin Proc 1986; 61:313-20.
19. Sedlis S P, Schechtman K B, Ludbrook P A, Sorel B E, Schonfeld G. Plasma apoproteins and the severity of coronary artery disease. Circulation 1986; 73: 978-86.
20. Kannel W B, Wolf P A, Castelli W P, d’Agostino R B. Fibrinogen and risk of cardiovascular disease. JAMA 1987; 258: 1183-6.
21. Stone M C, Thorpe J M. Plasma fibrinogen—A major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-9.
22. Meade T W, Mellows S, Brozovic M. etal. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-7.
23. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311:501-5.
24. Balleisen L, Bailey J, Epping P H, Schulte H, Van de Loo J., Epidemiological study on Factor VII, Factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body weight, smoking, pill-using and menopause. Thromb Haemosi 1985; 54: 475-9.
25. Meade T W, Haines A P, Imeson J D, Stirling Y, Thompson S G. Menopausal status and haemostatic variables. Lancet 1983; I: 22-4.
26. Roeschlau P, Bernt E, Gruber W. Enzymatic determination of total cholesterol in serum. Z Klin Chem Klin Biochem 1974; 12: 226-7.
27. Fossati P, Principle L. Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28: 2077-80.
28. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6:24.
29. Fruchart J C, Beucler I, Blaton V, etal., Me’thode selectionnge pour le dosage du cholesterol des lipoproteines non precipitables par le phosphotungstate de sodium en presence du chlorure de magnesium. Information Scienlifique du Biologiste 1982; 2: 69-72.
30. Friedewald W T, Levy R I, Frederickson D S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of separate centrifuge. Clin Chem 1972; 18: 599.
31. Clauss A von. Gerinnungsphysiologische schnell—methode zur bestimmung des fibrinogens. Acta Haemal 1957; 17: 231.
32. Hamman R F, Bennett P H, Miller M. The effect of menopause on serum cholesterol in American (pima) Indian women. Am J Epidemiol 1975; 102: 164-9.
33. Ernster V L, Bush T L, Huggins G R, Hulka B S, Kelsey J L, Schottenfeld D. Benefits and risks of menopausal estrogen and/or progestin hormone use. Prev Med 1988; 17: 201-23.
34. Godsland I F, Wynn V, Crook D, Miller N E., Sex, plasma lipoproteins and atherosclerosis: Prevailing assumptions and outstanding questions. Am Heart J 1987; 114: 1467-503.
35. Bush T L, Fried L P, Barrett-Connor E. Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem 1988; 34: B60-B70.
36. Kannel W B. High density lipoproteins: Epidemiologic profile and risk of coronary heart disease. Am J Cardiol 1983; 52:9B-12B.
37. Reardon M F, Nestel P J, Craig I H, Harper R W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985; 71: 881-8.